Yuasa K, Sugiyama M
Institute of Pharmaceutical Sciences, Hiroshima University School of Medicine, Japan.
FEMS Microbiol Lett. 1995 Oct 1;132(1-2):61-6. doi: 10.1111/j.1574-6968.1995.tb07811.x.
A bleomycin-resistance gene, designated blmA, has been cloned from bleomycin-producing Streptomyces verticillus by Sugiyama et al. (Gene 151 (1994) 11-16). The present study shows that Escherichia coli harboring the blmA-carrying pUC plasmid overproduced beta-lactamase, encoded by an ampicillin-resistance gene on the plasmid, when cultured in the presence of bleomycin, which suggests that bleomycin may act as an inducer (or an activator) for the expression of the specific gene in the presence of blmA. We constructed a vector, designated pMAB50, which senses bleomycin and produces a pigment, using blmA and a Streptomyces tyrosinase gene located under the control of beta-lactamase promoter: E. coli harboring pMAB50 produced the melanin pigment in the presence of bleomycin-type antibiotics, suggesting that the transformed E. coli can be employed as a reporter organism to screen bleomycin analogues.
杉山等人(《基因》第151卷,第11 - 16页,1994年)从产博来霉素的轮状链霉菌中克隆出一个名为blmA的博来霉素抗性基因。本研究表明,携带含blmA的pUC质粒的大肠杆菌在博来霉素存在的情况下培养时,会过量产生由质粒上的氨苄青霉素抗性基因编码的β - 内酰胺酶,这表明在blmA存在时,博来霉素可能作为特定基因表达的诱导剂(或激活剂)。我们构建了一个名为pMAB50的载体,它利用blmA和位于β - 内酰胺酶启动子控制下的链霉菌酪氨酸酶基因来感应博来霉素并产生色素:携带pMAB50的大肠杆菌在博来霉素类抗生素存在时会产生黑色素,这表明转化后的大肠杆菌可作为报告生物体用于筛选博来霉素类似物。